Scientists test re-engineered immune cells to fight tough cancers
NCT ID NCT07342738
Summary
This early-phase study is testing a new type of cell therapy called TCR-T for people with advanced solid tumors that have specific KRAS gene mutations. It aims to see if it is safe and if it can help control the cancer. The treatment involves collecting a patient's own immune cells, modifying them in a lab to better target the cancer, and then infusing them back into the patient after a short course of chemotherapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.